vs

Side-by-side financial comparison of Globalstar, Inc. (GSAT) and HARROW, INC. (HROW). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $72.0M, roughly 1.2× Globalstar, Inc.). HARROW, INC. runs the higher net margin — 7.4% vs -16.1%, a 23.6% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 17.6%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 12.9%).

Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

GSAT vs HROW — Head-to-Head

Bigger by revenue
HROW
HROW
1.2× larger
HROW
$89.1M
$72.0M
GSAT
Growing faster (revenue YoY)
HROW
HROW
+15.7% gap
HROW
33.3%
17.6%
GSAT
Higher net margin
HROW
HROW
23.6% more per $
HROW
7.4%
-16.1%
GSAT
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
12.9%
GSAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GSAT
GSAT
HROW
HROW
Revenue
$72.0M
$89.1M
Net Profit
$-11.6M
$6.6M
Gross Margin
79.3%
Operating Margin
-0.5%
17.5%
Net Margin
-16.1%
7.4%
Revenue YoY
17.6%
33.3%
Net Profit YoY
76.9%
-2.2%
EPS (diluted)
$-0.11
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GSAT
GSAT
HROW
HROW
Q4 25
$72.0M
$89.1M
Q3 25
$73.8M
$71.6M
Q2 25
$67.1M
$63.7M
Q1 25
$60.0M
$47.8M
Q4 24
$61.2M
$66.8M
Q3 24
$72.3M
$49.3M
Q2 24
$60.4M
$48.9M
Q1 24
$56.5M
$34.6M
Net Profit
GSAT
GSAT
HROW
HROW
Q4 25
$-11.6M
$6.6M
Q3 25
$1.1M
$1.0M
Q2 25
$19.2M
$5.0M
Q1 25
$-17.3M
$-17.8M
Q4 24
$-50.2M
$6.8M
Q3 24
$9.9M
$-4.2M
Q2 24
$-9.7M
$-6.5M
Q1 24
$-13.2M
$-13.6M
Gross Margin
GSAT
GSAT
HROW
HROW
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
GSAT
GSAT
HROW
HROW
Q4 25
-0.5%
17.5%
Q3 25
13.8%
20.6%
Q2 25
9.2%
17.9%
Q1 25
-14.2%
-23.5%
Q4 24
-6.9%
19.3%
Q3 24
13.0%
2.7%
Q2 24
-2.4%
3.1%
Q1 24
-8.3%
-20.0%
Net Margin
GSAT
GSAT
HROW
HROW
Q4 25
-16.1%
7.4%
Q3 25
1.5%
1.4%
Q2 25
28.6%
7.8%
Q1 25
-28.9%
-37.2%
Q4 24
-82.1%
10.1%
Q3 24
13.7%
-8.6%
Q2 24
-16.0%
-13.2%
Q1 24
-23.4%
-39.2%
EPS (diluted)
GSAT
GSAT
HROW
HROW
Q4 25
$-0.11
$0.20
Q3 25
$-0.01
$0.03
Q2 25
$0.13
$0.13
Q1 25
$-0.16
$-0.50
Q4 24
$-0.57
$0.19
Q3 24
$0.00
$-0.12
Q2 24
$-0.01
$-0.18
Q1 24
$-0.01
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GSAT
GSAT
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$447.5M
$72.9M
Total DebtLower is stronger
$483.8M
$250.0M
Stockholders' EquityBook value
$355.7M
$52.4M
Total Assets
$2.3B
$399.5M
Debt / EquityLower = less leverage
1.36×
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GSAT
GSAT
HROW
HROW
Q4 25
$447.5M
$72.9M
Q3 25
$346.3M
$74.3M
Q2 25
$308.2M
$53.0M
Q1 25
$241.4M
$66.7M
Q4 24
$391.2M
$47.2M
Q3 24
$51.9M
$72.6M
Q2 24
$64.3M
$71.0M
Q1 24
$59.3M
$76.0M
Total Debt
GSAT
GSAT
HROW
HROW
Q4 25
$483.8M
$250.0M
Q3 25
$508.6M
$347.2M
Q2 25
$491.5M
$250.6M
Q1 25
$502.7M
$256.9M
Q4 24
$511.4M
$262.7M
Q3 24
$394.4M
$230.7M
Q2 24
$393.1M
$236.3M
Q1 24
$398.7M
$243.4M
Stockholders' Equity
GSAT
GSAT
HROW
HROW
Q4 25
$355.7M
$52.4M
Q3 25
$364.8M
$47.0M
Q2 25
$360.9M
$49.7M
Q1 25
$344.3M
$56.5M
Q4 24
$358.9M
$69.7M
Q3 24
$394.1M
$58.0M
Q2 24
$383.0M
$58.5M
Q1 24
$377.1M
$60.6M
Total Assets
GSAT
GSAT
HROW
HROW
Q4 25
$2.3B
$399.5M
Q3 25
$2.2B
$363.1M
Q2 25
$1.9B
$345.0M
Q1 25
$1.7B
$364.2M
Q4 24
$1.7B
$389.0M
Q3 24
$917.6M
$351.5M
Q2 24
$926.2M
$306.6M
Q1 24
$917.0M
$295.5M
Debt / Equity
GSAT
GSAT
HROW
HROW
Q4 25
1.36×
4.77×
Q3 25
1.39×
7.39×
Q2 25
1.36×
5.05×
Q1 25
1.46×
4.55×
Q4 24
1.43×
3.77×
Q3 24
1.00×
3.98×
Q2 24
1.03×
4.04×
Q1 24
1.06×
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GSAT
GSAT
HROW
HROW
Operating Cash FlowLast quarter
$175.9M
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GSAT
GSAT
HROW
HROW
Q4 25
$175.9M
$8.4M
Q3 25
$236.0M
$16.6M
Q2 25
$157.9M
$-803.0K
Q1 25
$51.9M
$19.7M
Q4 24
$340.7M
$-17.8M
Q3 24
$32.0M
$3.0M
Q2 24
$36.7M
$-2.7M
Q1 24
$29.8M
$-4.6M
Free Cash Flow
GSAT
GSAT
HROW
HROW
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
Q1 24
$-4.7M
FCF Margin
GSAT
GSAT
HROW
HROW
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Q1 24
-13.6%
Capex Intensity
GSAT
GSAT
HROW
HROW
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Q1 24
0.3%
Cash Conversion
GSAT
GSAT
HROW
HROW
Q4 25
1.27×
Q3 25
216.53×
16.26×
Q2 25
8.22×
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
3.23×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GSAT
GSAT

Services$67.4M94%
Products$4.6M6%

HROW
HROW

Segment breakdown not available.

Related Comparisons